These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15367547)

  • 1. Genetic polymorphisms and statin therapy.
    Zineh I
    JAMA; 2004 Sep; 292(11):1302-3. PubMed ID: 15367547
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Marian AJ
    Curr Atheroscler Rep; 2005 May; 7(3):177-8. PubMed ID: 15811249
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
    JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE gene polymorphisms and response to statin therapy.
    Zintzaras E; Kitsios GD; Triposkiadis F; Lau J; Raman G
    Pharmacogenomics J; 2009 Aug; 9(4):248-57. PubMed ID: 19529002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New guidelines in statin therapy.
    Dinman S
    Plast Surg Nurs; 2005; 25(2):109-10. PubMed ID: 15983503
    [No Abstract]   [Full Text] [Related]  

  • 6. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol--frequently asked questions.
    Phillips PJ; Phillipov G
    Aust Fam Physician; 2006 Aug; 35(8):595-6. PubMed ID: 16894432
    [No Abstract]   [Full Text] [Related]  

  • 8. Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins.
    Chien KL; Wang KC; Chen YC; Chao CL; Hsu HC; Chen MF; Chen WJ
    Pharmacogenomics; 2010 Mar; 11(3):309-17. PubMed ID: 20235787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNP of HMGCR and Apo E genes and their impact in response to statin therapy in hypercholesterolemic and hypertriglyceridemic patients in Pakistan.
    Rizwan M; Aslam N; Ashfaq UA; Hayat M; Hussain SM
    Pak J Pharm Sci; 2021 Jul; 34(4(Supplementary)):1577-1583. PubMed ID: 34799335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH; Paramsothy P
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract]   [Full Text] [Related]  

  • 12. Are Patients with Low Non-HDL Cholesterol "Non-responders" to Statin Therapy on Coronary Plaque Regression?
    Koba S
    J Atheroscler Thromb; 2016 Sep; 23(9):1030-2. PubMed ID: 27397478
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Langmann T
    Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.
    Leduc V; Bourque L; Poirier J; Dufour R
    Pharmacogenet Genomics; 2016 Jan; 26(1):1-11. PubMed ID: 26466344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid lowering by rosuvastatin: how do statins differ?].
    Laufs U
    Dtsch Med Wochenschr; 2015 Mar; 140(5):313. PubMed ID: 25734669
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin therapy for healthy men identified as "increased risk".
    Blaha MJ; Nasir K; Blumenthal RS
    JAMA; 2012 Apr; 307(14):1489-90. PubMed ID: 22496260
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
    Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
    Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.